Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Phospholamban anticorps (pSer16) (PE)

L’anticorps Lapin Polyclonal anti-Phospholamban a été validé pour FACS. Il convient pour détecter Phospholamban dans des échantillons de Humain, Rat et Souris.
N° du produit ABIN2178506

Aperçu rapide pour Phospholamban anticorps (pSer16) (PE) (ABIN2178506)

Antigène

Voir toutes Phospholamban (PLN) Anticorps
Phospholamban (PLN)

Reactivité

  • 83
  • 22
  • 21
  • 3
  • 2
  • 2
  • 2
Humain, Rat, Souris

Hôte

  • 84
  • 2
  • 1
Lapin

Clonalité

  • 83
  • 4
Polyclonal

Conjugué

  • 41
  • 6
  • 5
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp Phospholamban est conjugé à/à la PE

Application

  • 36
  • 32
  • 26
  • 26
  • 18
  • 9
  • 9
  • 9
  • 8
  • 7
  • 6
  • 6
  • 1
  • 1
Flow Cytometry (FACS)
  • Épitope

    • 25
    • 17
    • 12
    • 9
    • 8
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer16

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic phosphopeptide derived from human Cardiac phospholamban around the phosphorylation site of Ser16

    Isotype

    IgG
  • Indications d'application

    FCM: (1:20-100)
    Optimal working dilution should be determined by the investigator.

    Commentaires

    Exitation/Emission: 480,565nm/578nm

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at 4 °C for 12 months.
  • Antigène

    Phospholamban (PLN)

    Autre désignation

    Plb

    Sujet

    Defects in PLN are the cause of cardiomyopathy dilated type 1P (CMD1P) . Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.Defects in PLN are the cause of cardiomyopathy familial hypertrophic type 18 (CMH18) . CMH18 is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
    Synonyms: Phospholamban phospho S16, p-Phospholamban phospho S16, p-PLBS16, Cardiac phospholamban, CMD1P, PLB, PLN, PPLA_HUMAN.

    ID gène

    5350

    Pathways

    Negative Regulation of Transporter Activity
Vous êtes ici:
Chat with us!